St. Jude Medical (STJ) to Showcase New Lesion Assessment Technology at TCT 2010  
9/22/2010 9:48:02 AM

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, will highlight recently launched technology, including its new Optical Coherence Tomography (OCT) product platform, at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The new C7-XR™ OCT Intravascular Imaging System complements the company’s PressureWire™ Fractional Flow Reserve (FFR) measurement technology platform, offering physicians a new diagnostic standard for comprehensive intravascular lesion assessment.